24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publication dates

All regions

Breast Cancer Industry, March 2015 Market Reports from Top Publishers

You might be interested in: cancer, medical equipment, therapeutics, melanoma, prostate cancer, drug, mammography, medical center, colorectal cancer, oncology, ultrasound, magnetic resonance imaging, hospital, lymphoma, cancer drug.


 
1-10 of about 300 reports for Breast Cancer

Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across ...

Hormone Refractory Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Hormone Refractory Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Hormone Refractory Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and ...

Metastatic Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

Metastatic Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

  • $ 2 000
  • Industry report
  • February 2015
  • by Delve Insight

DelveInsight's, “Metastatic Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015”, Report provides comprehensive insights about phase III pipeline drugs and marketed ...

Japan Pharma  Outlook 2015: 2015 -Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives

Japan Pharma Outlook 2015: 2015 -Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives

  • $ 2 000
  • Industry report
  • January 2015
  • by MP Advisors

The new pricing system adopted in Japan from April -2014 (Annexure 1) is a game changer initiative. It pains most of the companies - whether generic or innovator. The most of the companies are revalidating ...

Global Pharma US & EU Outlook 2015  : First -In- Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies

Global Pharma US & EU Outlook 2015 : First -In- Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies

  • $ 2 000
  • Industry report
  • January 2015
  • by MP Advisors

Strategy Diversification Divested: Productivity measurements, Divestment of non-core assets resulting in healthy Cash position- Will accelerate Next wave of targeted acquisition. In the recent years several ...

Medical Industry Week 19 JANUARY 2015

Medical Industry Week 19 JANUARY 2015

  • $ 1 114
  • Industry report
  • January 2015
  • by Espicom Business Intelligence

Industry Trend Analysis - Covidien To Accelerate Medtronic's Strategic Triad Industry Brief - Deltex To Sell Fore-Sight Oximeters In UK/Ireland Industry Brief - Braun Becomes Exclusive Distributor Fo ...

Pathology in United States: Breast Cancer – Pipeline Review, H1 2012

Pathology in United States: Breast Cancer – Pipeline Review, H1 2012

  • $ 2 500
  • Industry report
  • January 2015
  • by Global Markets Direct

This report provides information on the therapeutic development for Breast Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

Pathology Industry: Brain Cancer – Pipeline Review, H1 2012

Pathology Industry: Brain Cancer – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

This report provides information on the therapeutic development for Brain Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players ...

H. Lee Moffitt Cancer Center & Research Institute, Inc. - Medical Equipment - Deals and Alliances Profile

H. Lee Moffitt Cancer Center & Research Institute, Inc. - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2015
  • by Global Data

Summary H. Lee Moffitt Cancer Center & Research Institute, Inc. (Moffitt) is a not-for-profit institution. It is involved in the prevention and cure of cancer through patient care, research and education. ...

Dana-Farber Cancer Institute, Inc. - Medical Equipment - Deals and Alliances Profile

Dana-Farber Cancer Institute, Inc. - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2015
  • by Global Data

Summary Dana-Farber Cancer Institute, Inc. (Dana-Farber) is a cancer research center. The center offers treatment for different types of cancers. It provides adults and children with various treatment ...

About 4 500 reports for Breast Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • January 2013
    40 pages
  • Breast Cancer  

    Cancer  

  • United States  

    North America  

View report >

4 Companies for Breast Cancer

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Eli Lilly and Co.

United States

Novartis Inc.

Switzerland

AstraZeneca PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.